JamesAlexanderMcKinnellMD
Infectious Disease • Torrance, CAAssistant Professor, Medicine, University of California Los Angeles David Geffen SOM
Dr. McKinnell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 W Carson St FL 2
Division of ID 2ND floor RB2
Torrance, CA 90502Phone+1 310-222-3814Fax+1 310-326-5679
Education & Training
University of Alabama Medical CenterFellowship, Infectious Disease, 2007 - 2009
Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 2004 - 2007
Columbia University Vagelos College of Physicians and SurgeonsClass of 2004
Certifications & Licensure
CA State Medical License 2006 - 2026
AL State Medical License 2007 - 2009- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Project CLEAR - Changing Lives by Eradicating Antibiotic Resistance Start of enrollment: 2011 Jan 01
- Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections Start of enrollment: 2014 May 01
- A Study of Baricitinib (LY3009104) in Participants With COVID-19 Start of enrollment: 2020 Jun 12
Publications & Presentations
PubMed
- 124 citationsPlazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae.James A. McKinnell, Jamie P. Dwyer, George H. Talbot, Lynn E. Connolly, Ian R. Friedland
The New England Journal of Medicine. 2019-02-20 - 184 citationsVaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention.Sarah M. Bartsch, Kelly J. O'Shea, Marie C. Ferguson, Maria Elena Bottazzi, Patrick T. Wedlock
American Journal of Preventive Medicine. 2020-07-15 - 39 citationsObservational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents.James A. McKinnell, Mukesh Patel, Rhett M. Shirley, Danielle F. Kunz, Stephen A. Moser
Epidemiology and Infection. 2011-09-01
Press Mentions
Remember Overwhelmed Hospitals Across the US Three Years Ago?January 28th, 2021
Plazomicin Noninferior to Meropenem for Complicated UTIFebruary 21st, 2019
Plazomicin for Tough Infections: A Tale of 2 Clinical TrialsFebruary 21st, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
